Fortress Biotech (FBIO) Research & Development (2010 - 2026)

Fortress Biotech's Research & Development history runs 16 years deep, the most recent figure standing at -$367000.0 for Q4 2025.

• In Q4 2025, Research & Development fell 103.79% year-over-year to -$367000.0; the TTM figure through Dec 2025 stood at $11.9 million (down 78.98% YoY), while the FY2025 annual figure was $11.9 million, down 78.98% from the prior year.
• Research & Development for Q4 2025 stood at -$367000.0, down from $208000.0 in the prior quarter.
• The five-year high for Research & Development was $43.1 million in Q4 2021, with the low at -$367000.0 in Q4 2025.
• The 5-year median for Research & Development is $21.6 million (2021), against an average of $21.1 million.
• The sharpest annual moves came in 2021 and 2025: Research & Development surged 571.5% in 2021, then sank 103.79% in 2025.
• Fortress Biotech's Research & Development stood at $43.1 million in 2021, then slipped by 19.89% to $34.5 million in 2022, then sank by 59.28% to $14.0 million in 2023, then sank by 31.02% to $9.7 million in 2024, then tumbled by 103.79% to -$367000.0 in 2025.
• Business Quant data shows FBIO's Research & Development at -$367000.0 in Q4 2025, $208000.0 in Q3 2025, and $8.1 million in Q2 2025.